Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

Timo Vesikari; Luis Rivera; Tiina Korhonen; Anitta Ahonen; Brigitte Cheuvart; Marjan Hezareh; Winnie Janssens; Narcisa Mesaros

doi:10.1080/21645515.2017.1294294

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

Timo Vesikari
, Luis Rivera
, Tiina Korhonen
, Anitta Ahonen
, Brigitte Cheuvart
, Marjan Hezareh
, Winnie Janssens
, Narcisa Mesaros

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

1 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	1505-1515
Julkaisu	Human Vaccines and Immunotherapeutics
Vuosikerta	13
Numero	7
DOI - pysyväislinkit	https://doi.org/10.1080/21645515.2017.1294294
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Tutkimusalat

DTPa-HBV-IPV/Hib
Haemophilus influenzae type b
acellular pertussis
diphtheria
hepatitis B
immunogenicity
infants
poliovirus
safety
tetanus

Julkaisufoorumi-taso

Jufo-taso 1

Pääsy asiakirjaan

10.1080/21645515.2017.1294294

http://urn.fi/URN:NBN:fi:uta-201708112255

Siteeraa tätä

Vesikari, T., Rivera, L., Korhonen, T., Ahonen, A., Cheuvart, B., Hezareh, M., Janssens, W., & Mesaros, N. (2017). Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa. Human Vaccines and Immunotherapeutics, 13(7), 1505-1515. https://doi.org/10.1080/21645515.2017.1294294

Vesikari, Timo ; Rivera, Luis ; Korhonen, Tiina et al. / Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa. Julkaisussa: Human Vaccines and Immunotherapeutics. 2017 ; Vuosikerta 13, Nro 7. Sivut 1505-1515.

@article{ec2faf33a367441097d38900a9eebcc8,

title = "Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa",

keywords = "DTPa-HBV-IPV/Hib, Haemophilus influenzae type b, acellular pertussis, diphtheria, hepatitis B, immunogenicity, infants, poliovirus, safety, tetanus, DTPa-HBV-IPV/Hib, Haemophilus influenzae type b, acellular pertussis, diphtheria, hepatitis B, immunogenicity, infants, poliovirus, safety, tetanus",

author = "Timo Vesikari and Luis Rivera and Tiina Korhonen and Anitta Ahonen and Brigitte Cheuvart and Marjan Hezareh and Winnie Janssens and Narcisa Mesaros",

year = "2017",

doi = "10.1080/21645515.2017.1294294",

language = "English",

volume = "13",

pages = "1505--1515",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "American School of Classical Studies at Athens",

number = "7",

}

Vesikari, T, Rivera, L, Korhonen, T, Ahonen, A, Cheuvart, B, Hezareh, M, Janssens, W & Mesaros, N 2017, 'Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa', Human Vaccines and Immunotherapeutics, Vuosikerta 13, Nro 7, Sivut 1505-1515. https://doi.org/10.1080/21645515.2017.1294294

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa. / Vesikari, Timo; Rivera, Luis; Korhonen, Tiina et al.
julkaisussa: Human Vaccines and Immunotherapeutics, Vuosikerta 13, Nro 7, 2017, s. 1505-1515.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

AU - Vesikari, Timo

AU - Rivera, Luis

AU - Korhonen, Tiina

AU - Ahonen, Anitta

AU - Cheuvart, Brigitte

AU - Hezareh, Marjan

AU - Janssens, Winnie

AU - Mesaros, Narcisa

PY - 2017

Y1 - 2017

KW - DTPa-HBV-IPV/Hib

KW - Haemophilus influenzae type b

KW - acellular pertussis

KW - diphtheria

KW - hepatitis B

KW - immunogenicity

KW - infants

KW - poliovirus

KW - safety

KW - tetanus

KW - DTPa-HBV-IPV/Hib

KW - Haemophilus influenzae type b

KW - acellular pertussis

KW - diphtheria

KW - hepatitis B

KW - immunogenicity

KW - infants

KW - poliovirus

KW - safety

KW - tetanus

U2 - 10.1080/21645515.2017.1294294

DO - 10.1080/21645515.2017.1294294

M3 - Article

SN - 2164-5515

VL - 13

SP - 1505

EP - 1515

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 7

ER -

Vesikari T, Rivera L, Korhonen T, Ahonen A, Cheuvart B, Hezareh M et al. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa. Human Vaccines and Immunotherapeutics. 2017;13(7):1505-1515. doi: 10.1080/21645515.2017.1294294